153OM7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): Efficacy by BTC subtype. (25th November 2018) - Yoo, C; Oh, D-Y; Choi, H J; Kudo, M; Ueno, M; Kondo, S; Chen, L-T; Osada, M; Helwig, C; Dussault, I; Ikeda, M